CM – Pfizer reports positive results from the JADE DARE phase 3 study in atopic dermatitis

0

Keywords:

Pfizer,Atopic dermatitis,Dupilumab,NYSE:PFE,Clinical trial,Pfizer, Atopic dermatitis, Dupilumab, NYSE:PFE, Clinical trial,,arrest,cardiovascular,childhood,children,chronic,covid-19,disease,immunology,Impact,inflammation,participants,Pfizer,rating,Safety,tablet,treatment,,

Donnez votre avis et abonnez-vous pour plus d’infos

[gs-fb-comments]

Vidéo du jour: